Nutreco
- Consolidated income statement
- Consolidated statement of comprehensive income
- Consolidated balance sheet
- Statement of changes in equity
- Consolidated cash flow statement
- Notes to the consolidated financial statements
- (1) Accounting policies used for the consolidated financial statements of Nutreco Holding N.V.
- (2) Reconciliation consolidated income statement
- (3) Operating segments
- (4) Discontinued operations and divestments
- (5) Assets and liabilities held for sale
- (6) Acquisitions
- (7) Other operating income
- (8) Personnel costs
- (9) Other operating expenses
- (10) Net financing costs
- (11) Income tax expense
- (12) Earnings per share
- (13) Property, plant and equipment
- (14) Intangible assets
- (15) Investments in associates
- (16) Other investments
- (17) Deferred tax assets and liabilities
- (18) Inventories
- (19) Biological assets
- (20) Trade and other receivables
- (21) Cash and cash equivalents
- (22) Equity attributable to the equity holders of the parent
- (23) Interest-bearing borrowings
- (24) Employee benefits
- (25) Provisions
- (26) Trade and other payables
- (27) Financial instruments and risk management
- (28) Contingent assets and liabilities
- (29) Related party transactions
- (30) Subsequent events
- (31) Accounting estimates and judgements
- (32) Notes to the consolidated cash flow statement
Consolidated income statement
|
(EUR x million) |
Note |
2009 |
2008¹ |
|
Revenue |
4,511.7 |
4,943.1 |
|
|
Raw materials and consumables used |
-3,573.5 |
-4,008.5 |
|
|
Change in fair value of biological assets |
2.2 |
-0.5 |
|
|
Changes in inventories of finished goods and work in progress |
|
4.3 |
7.6 |
|
Gross margin |
944.7 |
941.7 |
|
|
Other operating income |
36.4 |
29.9 |
|
|
Personnel costs |
-441.7 |
-427.5 |
|
|
Depreciation and amortisation expenses |
-64.8 |
-61.4 |
|
|
Impairment of long-lived assets |
-9.1 |
-0.1 |
|
|
Other operating expenses |
-307.6 |
-310.5 |
|
|
Operating result from continuing operations |
157.9 |
172.1 |
|
|
Financial income |
5.9 |
6.3 |
|
|
Financial expenses |
-38.3 |
-38.1 |
|
|
Foreign exchange result |
0.8 |
0.6 |
|
|
Net financing costs/income |
-31.6 |
-31.2 |
|
|
Share in results of associates |
1.4 |
2.1 |
|
|
Result before tax from continuing operations |
127.7 |
143.0 |
|
|
Income tax expense |
-34.7 |
-37.2 |
|
|
Result after tax from continuing operations |
93.0 |
105.8 |
|
|
Result after tax from discontinued operations |
- |
11.1 |
|
|
Gain on sale of discontinued operations, net of income tax |
- |
- |
|
|
Result after tax from discontinued operations |
- |
11.1 |
|
|
Total result for the period |
93.0 |
116.9 |
|
|
Attributable to: |
|||
|
Equity holders of Nutreco |
90.3 |
114.8 |
|
|
Minority interest |
2.7 |
2.1 |
|
|
Total result for the period |
93.0 |
116.9 |
|
|
Key figures per share for continuing operations |
|||
|
Basic earnings per share for continuing operations (EUR) |
2.61 |
3.02 |
|
|
Diluted earnings per share for continuing operations (EUR) |
2.61 |
3.02 |
|
|
Earnings per share for dividend calculation (EUR) |
2.93 |
3.18 |
|
|
Weighted average number of ordinary shares outstanding during the year (x 1,000) |
34,603 |
34,358 |
|
|
Weighted average number of ordinary shares for diluted earnings per share (x 1,000) |
34,607 |
34,365 |
|
|
Number of ordinary shares outstanding as at 31 December (x 1,000) |
34,995 |
34,279 |
|
|
Key figures per share (EUR) |
|||
|
Basic earnings per share |
2.61 |
3.34 |
|
|
Diluted earnings per share |
2.61 |
3.34 |
|
|
Key figures operating result for continuing operations |
|||
|
Earnings Before Interest, Tax and Amortisation (EBITA) |
170.0 |
182.9 |
|
|
Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) |
222.7 |
233.5 |
¹ Raw materials and consumables used are increased with EUR 25.0 million for the freight costs, which were reported under other operating expenses.